Glaukos (GKOS) insider trading in the last 6 months
Form 4 filings, newest first
4 insiders sold $15.2M. No buys.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Who files at Glaukos
Questions about GKOS's insider trades
Are GKOS insiders buying or selling?
4 insiders sold $15.2M across 9 filings in the last 6 months. No open-market buys on record. The newest filing: Tomas Navratil, Chief Development Officer, sold $1.4M on Aug 28, 2026.
Who are GKOS's biggest insider sellers?
By the dollars of their sales in the last 6 months: Joseph E. Gilliam (President & COO), 2 sales; Tomas Navratil (Chief Development Officer), 3 sales; Gilbert H. Kliman (Director), 3 sales. 4 insiders sold in all.
When did a GKOS insider last buy?
No GKOS insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Tomas Navratil on Aug 28, 2026.
Glaukos's page has its Quality Score, its chart, and its earnings. More in Healthcare and Medical Devices.